Can Gout Flare Temporarily Worsen When Starting Urate Therapy? 

It is a common and understandably frustrating experience for patients in the UK to find that their gout attacks actually increase shortly after starting a preventative medication. This phenomenon, known as an initiation flare, can make it feel as though the treatment is failing or even making the condition worse. However, in most cases, the opposite is true. A temporary increase in flares is often a physical sign that the medication is working to shift and dissolve the crystal deposits in your joints. Understanding why this happens is essential for staying committed to your long term treatment plan. 

What We Will Discuss in This Article 

• The biological reason why lowering uric acid can trigger a flare 

• Why the shifting and shedding of crystals causes joint irritation 

• The importance of prophylaxis (preventative cover) during the first six months 

• Why you must not stop your medication if an initiation flare occurs 

• How the treat to target approach eventually leads to a flare free life 

• When a severe joint flare requires an urgent clinical review via 999 

Why Initiation Flares Happen 

To understand why your gout might worsen temporarily, it helps to imagine the crystals in your joints like a stack of precariously balanced needles. For years, these crystals have been packed into your joint cartilage and tendons. 

When you start a medication like allopurinol or febuxostat, the concentration of uric acid in your blood drops. This change in blood chemistry causes the edges of the crystal deposits to start dissolving. As they dissolve, the structure of the crystal “pile” becomes unstable. Small shards can break off or shift, tickling the sensitive lining of the joint and triggering the immune system to launch an inflammatory attack. 

According to NICE clinical guidelines, this is a normal part of the dissolution phase. The medication is effectively cleaning your joints, but the process of moving those crystals out can be physically irritating in the short term. 

The Role of Prophylaxis (Preventative Cover) 

Because initiation flares are so common, UK doctors rarely prescribe urate lowering therapy on its own. Instead, they provide a “safety net” of anti inflammatory medication to cover the first few months of treatment. This is known as prophylaxis. 

The most common approach in the UK is to prescribe a low dose of colchicine (usually one 500 microgram tablet once or twice a day) for the first six months of your new treatment. If you cannot take colchicine, your GP might suggest a low dose NSAID instead. This preventative cover is designed to keep your immune system calm while the uric acid levels are shifting, significantly reducing the risk of a major attack. 

Why You Must Continue Your Medication 

If you experience a flare after starting allopurinol, your first instinct might be to stop taking it. However, this is the most important time to stay consistent. Stopping and starting urate lowering therapy causes your uric acid levels to “yo-yo,” which is one of the most powerful triggers for severe and prolonged gout attacks. 

If a flare occurs, you should continue with your daily preventative dose and use your acute rescue medication (such as naproxen or a higher dose of colchicine) to manage the pain. By pushing through this transition phase, you allow the medication to continue its work of clearing the crystals for good. 

The Recovery Timeline 

Initiation flares are a temporary hurdle. As your body clears the backlog of crystals, the frequency and intensity of these attacks will steadily decrease. 

Phase of Treatment	Typical Experience
Months 1 to 3	Highest risk of initiation flares; shifting crystals are most active.
Months 3 to 6	Flares become less frequent and easier to manage with prophylaxis.
Months 6 to 12	Most patients find their gout has settled as crystal stores are depleted.
Year 1 onwards	Long term stability; flares should be rare if the target level is maintained.

Managing Your Expectations 

In the UK, the goal of treatment is to move you toward a flare free life, but this process takes time. It is helpful to view any flares during the first few months not as a setback, but as evidence that the “cleaning process” is underway. By maintaining your treat to target goal (usually below 360 µmol/L), you ensure that once these initial crystals are gone, they will not have the opportunity to form again. 

Conclusion 

It is entirely normal for gout flares to temporarily worsen when you first start urate lowering therapy. This initiation flare is caused by the physical shifting and dissolving of crystal deposits as your blood chemistry improves. By using preventative anti inflammatory cover and staying consistent with your daily dose, you can navigate this transition phase safely. Remember that these temporary flares are a stepping stone toward a future where your joints are clear, healthy, and pain free. 

If you experience severe, sudden joint pain accompanied by a high temperature, chills, or feeling generally unwell, call 999 or go to A&E immediately, as this may be a sign of a serious infection. 

Authority Snapshot (E-E-A-T Block) 

This article was written by Dr. Stefan Petrov, a UK trained physician with an MBBS and experience in general medicine, surgery, and emergency care. Dr. Petrov has helped many patients navigate the transition to long term gout therapy, ensuring they understand the clinical progression and safety protocols according to NHS and NICE standards. This guide provides an authoritative overview of initiation flares in the UK.